Michael Bragin is a pharmaceutical forecasting, insights, and analytics professional with over 15 years of experience in the life sciences sector. They have played pivotal roles in tactical and strategic initiatives in oncology, neurology, dermatology, and rare diseases, supporting R&D portfolio prioritization and corporate development projects. Currently, Michael serves as the Director of BD&L Forecasting and Analytics at CSL, driving decision-making through commercial revenue forecasting and product portfolio analytics. They hold multiple degrees, including a BA in Political Science from the University of California, Berkeley, and an MS in Biotechnology from the University of Wisconsin School of Medicine and Public Health.
This person is not in the org chart
This person is not in any teams
This person is not in any offices